Intratumoral injection of recombinant lentivirus-mediated Bmi1-shRNA inhibits growth of A549 xenografts in mice

Zhou Jing,Xu Yu,Zhang Minghui,Hu Yide
2010-01-01
Abstract:Objective To investigate the inhibitory effect of lentivirus-mediated Bmi1-shRNA on transplanted human non-small cell lung cancer(NSCLC)by intratumoral injection.MethodsRecombinant lentivirus containing Bmi1-shRNA was constructed.A model of subcutaneous implanted tumor was generated through injecting human lung cancer cell A549(107)into the NOD/SCID mice.The 27 established mice with a mass at a diameter of 4 to 5 mm were divided into 3 groups randomly and equally.Recombinant lentivirus containing Bmi1-shRNA(5×108 TU/ml,0.1 ml),lentivirus containing NC-shRNA(5×108 TU/ml,0.1 ml,as negative controls)and PBS(0.1 ml,as blank control)was given the mice of the 3 groups respectively,once per 3 d,for 4 weeks.The size of the tumor mass were measured every 3 d.The mice were sacrificed in the end of 4 weeks' treatment.The expression of GFP in the xenografts was detected through laser scanning confocal microscope.RT-PCR and Western blot analysis were used to test the mRNA and protein expressions of Bmi1 in the xenografts.Results GFP was expressed in the tumor mass of the recombinant lentivirus groups,but not in the blank control.The average tumor volume in Bmi1-shRNA lentivirus group was significantly lower than that in the negative control and blank control groups(P<0.05)with an inhibitory rate of 52.9 % and 57.9% respectively.RT-PCR and Western blotting showed that the mRNA and protein expression of Bmi1 was decreased in the Bmi1-shRNA lentivirus group(P<0.05).ConclusionIntratumoral injection of recombinant Bmi1-shRNA Lentivirus inhibits the growth and proliferation of A549 xenografts in the NOD/SCID mice,suggesting that Bmi1 might represent a therapeutic target in the genotherapies of non-small cell lung cancer.
What problem does this paper attempt to address?